Fidelity Investments
PROK icon

Fidelity Investments’s ProKidney PROK Stock Holding History

Fidelity Investments’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4K Sell
10,254
-56
-0.5% -$119 ﹤0.01% 4549
2025
Q4 		$23.1K Sell
10,310
-1,591
-13% -$4.18K ﹤0.01% 4411
2025
Q3 		$28.8K Sell
11,901
-53,674
-82% -$143K ﹤0.01% 4205
2025
Q2 		$38.8K Buy
65,575
+61,227
+1,408% +$47.7K ﹤0.01% 4011
2025
Q1 		$3.81K Sell
4,348
-2,293
-35% -$3.18K ﹤0.01% 4771
2024
Q4 		$11.2K Sell
6,641
-1,830
-22% -$3.3K ﹤0.01% 4432
2024
Q3 		$16.3K Buy
8,471
+36
+0.4% +$82 ﹤0.01% 4264
2024
Q2 		$20.8K Sell
8,435
-235,678
-97% -$633K ﹤0.01% 4054
2024
Q1 		$400K Buy
244,113
+241,764
+10,292% +$355K ﹤0.01% 2799
2023
Q4 		$4.18K Buy
2,349
+1,319
+128% +$2.83K ﹤0.01% 4502
2023
Q3 		$4.72K Buy
1,030
+525
+104% +$5.03K ﹤0.01% 4343
2023
Q2 		$5.66K Buy
+505
New +$5.38K ﹤0.01% 4327

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments's PROK Position: Q1 2026 in Review

Fidelity Investments reduced its ProKidney (PROK) stake by 0.54% in Q1 2026, selling an estimated $119 and leaving 10,254 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4549.

Fidelity Investments first reported a position in PROK in Q2 2023 and has held it in 12 quarters since. The position peaked at $400K in Q1 2024. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Fidelity Investments held 10,254 shares of ProKidney worth $18.4K as of Q1 2026.
  • Fidelity Investments sold 56 ProKidney shares in Q1 2026, an estimated $119.
  • ProKidney made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4549 holding.
  • Fidelity Investments first reported a position in ProKidney in Q2 2023 and has held it in 12 quarters since.
  • Fidelity Investments's ProKidney position peaked at $400K in Q1 2024.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.